Literature DB >> 25146456

RIT2, a susceptibility gene for Parkinson's disease in Iranian population.

Babak Emamalizadeh1, Abolfazl Movafagh1, Mojdeh Akbari1, Somayyeh Kazeminasab2, Atena Fazeli1, Marzieh Motallebi1, Gholam-Ali Shahidi3, Peyman Petramfar4, Reza Mirfakhraie5, Hossein Darvish6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25146456     DOI： 10.1016/j.neurobiolaging.2014.07.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN： 0197-4580            Impact factor:   4.673


× No keyword cloud information.
  10 in total

1.  The human RIT2 core promoter short tandem repeat predominant allele is species-specific in length: a selective advantage for human evolution?

Authors:  Babak Emamalizadeh; Abofazl Movafagh; Hossein Darvish; Somayeh Kazeminasab; Monavvar Andarva; Pegah Namdar-Aligoodarzi; Mina Ohadi
Journal:  Mol Genet Genomics       Date:  2017-02-18       Impact factor: 3.291

Review 2.  CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.

Authors:  Fatemeh Safari; Gholamreza Hatam; Abbas Behzad Behbahani; Vahid Rezaei; Mazyar Barekati-Mowahed; Peyman Petramfar; Farzaneh Khademi
Journal:  Cell Mol Neurobiol       Date:  2019-11-26       Impact factor: 5.046

3.  Genetic association study between RIT2 and Parkinson's disease in a Han Chinese population.

Authors:  Jun-Ying Li; Jin-Hong Zhang; Nan-Nan Li; Ling Wang; Zhong-Jiao Lu; Lan Cheng; Xiao-Yi Sun; Rong Peng
Journal:  Neurol Sci       Date:  2016-11-26       Impact factor: 3.307

4.  Genetic Analysis of the ZNF512B, SLC41A1, and ALDH2 Polymorphisms in Parkinson's Disease in the Iranian Population.

Authors:  Faranak Madadi; Mahmoud Shekari Khaniani; Ehsan Esmaili Shandiz; Hormoz Ayromlou; Safa Najmi; Babak Emamalizadeh; Shaghayegh Taghavi; Javad Jamshidi; Abbas Tafakhori; Gholam-Ali Shahidi; Hossein Darvish
Journal:  Genet Test Mol Biomarkers       Date:  2016-09-09

5.  RIT2 Polymorphisms: Is There a Differential Association?

Authors:  Babak Emamalizadeh; Javad Jamshidi; Abolfazl Movafagh; Mina Ohadi; Mahmoud Shekari Khaniani; Somayyeh Kazeminasab; Akbar Biglarian; Shaghayegh Taghavi; Marzieh Motallebi; Atena Fazeli; Azadeh Ahmadifard; Gholam-Ali Shahidi; Peyman Petramfar; Neda Shahmohammadibeni; Tahereh Dadkhah; Ehteram Khademi; Abbas Tafakhori; Ali Khaligh; Tannaz Safaralizadeh; Ali Kowsari; Arash Mirabzadeh; Amir Ehtesham Shafiei Zarneh; Mehdi Khorrami; Parasto Shokraeian; Mohammad Javad Soltani Banavandi; Behnam Safarpour Lima; Monavvar Andarva; Elham Alehabib; Minoo Atakhorrami; Hossein Darvish
Journal:  Mol Neurobiol       Date:  2016-03-03       Impact factor: 5.590

Review 6.  RIT2: responsible and susceptible gene for neurological and psychiatric disorders.

Authors:  Yousef Daneshmandpour; Hossein Darvish; Babak Emamalizadeh
Journal:  Mol Genet Genomics       Date:  2018-06-02       Impact factor: 3.291

7.  Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster.

Authors:  Rita R Fagan; Patrick J Kearney; Dino Luethi; Nicholas C Bolden; Harald H Sitte; Patrick Emery; Haley E Melikian
Journal:  Mol Psychiatry       Date:  2021-09-01       Impact factor: 13.437

8.  Lack of Altered BECN1 Gene Expression in Iranian Patients with Acute Myeloid Leukemia

Authors:  Ladan Keyvan; Seyed Kazem Bidoki; Davood Zare Abdollahi; Neda Mansouri; Mehrdad Hashemi; Sa Mortazavi Tabatabaei; Hediyeh Fardmanesh; Mansour Meimandi; Seyed Majid Ayatollahi; Hasan Jalaeikhoo; Abolfazl Movafagh
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

Review 9.  Dynamic control of the dopamine transporter in neurotransmission and homeostasis.

Authors:  Mengfei Bu; Matthew J Farrer; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2021-03-05

Review 10.  Genetic association of RIT2 rs12456492 polymorphism and Parkinson's disease susceptibility in Asian populations: a meta-analysis.

Authors:  Yanjun Lu; Wei Liu; Kun Tan; Jing Peng; Yaowu Zhu; Xiong Wang
Journal:  Sci Rep       Date:  2015-09-03       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.